Daniel J Drucker1. Show Affiliations » 1. Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ont. d.drucker@utoronto.ca
Abstract
Entities: Disease
Mesh: See more » AnimalsAwards and PrizesDiabetes Mellitus, Type 2/drug therapyDipeptidyl Peptidase 4/therapeutic useDipeptidyl-Peptidase IV Inhibitors/therapeutic useGastrointestinal Diseases/drug therapyGlucagon-Like Peptide 1/therapeutic useGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptides/therapeutic useHumansMetabolic Diseases/drug therapyReceptors, Glucagon/agonists
Substances: See more » Dipeptidyl-Peptidase IV InhibitorsGLP1R protein, humanGlucagon-Like Peptide-1 ReceptorReceptors, GlucagonGlucagon-Like PeptidesGlucagon-Like Peptide 1Dipeptidyl Peptidase 4
Year: 2012 PMID: 22271921 PMCID: PMC3273536 DOI: 10.1503/cmaj.112127
Source DB: PubMed Journal: CMAJ ISSN: 0820-3946 Impact factor: 8.262